“Immunogenicity and Safety of Cervarix HPV-16 18 AS04-Adjuvant Vaccine Against HPV Induced Cervical Cancer in Women (15+ Years)”. UCC Student Medical Journal 3 (October 10, 2024): 50–61. Accessed May 21, 2025. https://aigne.ucc.ie/index.php/smj/article/view/4323.